Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Ultralow Dose PET Imaging for Detecting PSMA Expression

NCT06904313 is registered in ClinicalTrials.gov with Akiva Mintz as lead sponsor.

NCT NCT06904313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06904313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Ultralow Dose PET Imaging for Detecting PSMA Expression
Lead sponsor
Akiva Mintz
Phase
Phase 2
Overall status
Recruiting
Start date
May 12, 2025
Completion date
June 30, 2030
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteer, prostate ca